These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6097348

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
    Tate JE, Mutter GL, Prasad CJ, Berkowitz R, Goodman H, Crum CP.
    Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
    Ocádiz R, Sauceda R, Salcedo M, Ortega V, Rodríguez H, Gordillo C, Chávez P, Gariglio P.
    Arch Invest Med (Mex); 1989 Apr; 20(4):355-62. PubMed ID: 2562235
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [The possibility of viral etiology in cervical carcinogenesis].
    Iwasaka T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):802-11. PubMed ID: 2172417
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
    Ocadiz R, Sauceda R, Cruz M, Graef AM, Gariglio P.
    Cancer Res; 1987 Aug 01; 47(15):4173-7. PubMed ID: 3300961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
    Riou G, Sheng ZM, Zhou D, Lusinchi A, Le Doussal V, Barrois M.
    Bull Cancer; 1990 Aug 01; 77(4):341-7. PubMed ID: 2191730
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
    Pelisson I, Soler C, Chardonnet Y, Euvrard S, Schmitt D.
    Cancer Detect Prev; 1996 Aug 01; 20(1):20-30. PubMed ID: 8907200
    [Abstract] [Full Text] [Related]

  • 15. Occurrence of human papillomavirus types 16 and 18 DNA in cervical carcinomas from Japan: age of patients and histological type of carcinomas.
    Yoshikawa H, Matsukura T, Yamamoto E, Kawana T, Mizuno M, Yoshiike K.
    Jpn J Cancer Res; 1985 Aug 01; 76(8):667-71. PubMed ID: 2995290
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genomic organization of amplified MYC genes suggests distinct mechanisms of amplification in tumorigenesis.
    Herrick J, Conti C, Teissier S, Thierry F, Couturier J, Sastre-Garau X, Favre M, Orth G, Bensimon A.
    Cancer Res; 2005 Feb 15; 65(4):1174-9. PubMed ID: 15735000
    [Abstract] [Full Text] [Related]

  • 19. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes.
    Medina-Martínez O, Vallejo V, Guido MC, García-Carrancá A.
    Mol Carcinog; 1997 Jun 15; 19(2):83-90. PubMed ID: 9210955
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.